Magnetic Resonance Imaging-Based Radiation-Absorbed Dose Estimation of {sup 166}Ho Microspheres in Liver Radioembolization
- Image Sciences Institute, University Medical Center Utrecht, Utrecht (Netherlands)
- Department of Nuclear Medicine, Amsterdam Medical Centre, Amsterdam (Netherlands)
- Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht (Netherlands)
Purpose: To investigate the potential of magnetic resonance imaging (MRI) for accurate assessment of the three-dimensional {sup 166}Ho activity distribution to estimate radiation-absorbed dose distributions in {sup 166}Ho-loaded poly (L-lactic acid) microsphere ({sup 166}Ho-PLLA-MS) liver radioembolization. Methods and Materials: MRI, computed tomography (CT), and single photon emission CT (SPECT) experiments were conducted on an anthropomorphic gel phantom with tumor-simulating gel samples and on an excised human tumor-bearing liver, both containing known amounts of {sup 166}Ho-PLLA-MS. Three-dimensional radiation-absorbed dose distributions were estimated at the voxel level by convolving the {sup 166}Ho activity distribution, derived from quantitative MRI data, with a {sup 166}Ho dose point-kernel generated by MCNP (Monte Carlo N-Particle transport code) and from Medical Internal Radiation Dose Pamphlet 17. MRI-based radiation-absorbed dose distributions were qualitatively compared with CT and autoradiography images and quantitatively compared with SPECT-based dose distributions. Both MRI- and SPECT-based activity estimations were validated against dose calibrator measurements. Results: Evaluation on an anthropomorphic phantom showed that MRI enables accurate assessment of local {sup 166}Ho-PLLA-MS mass and activity distributions, as supported by a regression coefficient of 1.05 and a correlation coefficient of 0.99, relating local MRI-based mass and activity calculations to reference values obtained with a dose calibrator. Estimated MRI-based radiation-absorbed dose distributions of {sup 166}Ho-PLLA-MS in an ex vivo human liver visually showed high correspondence to SPECT-based radiation-absorbed dose distributions. Quantitative analysis revealed that the differences in local and total amounts of {sup 166}Ho-PLLA-MS estimated by MRI, SPECT, and the dose calibrator were within 10%. Excellent agreement was observed between MRI- and SPECT-based dose-volume histograms. Conclusions: Quantitative MRI was demonstrated to provide accurate three-dimensional {sup 166}Ho-PLLA-MS activity distributions, enabling localized intrahepatic radiation-absorbed dose estimation by convolution with a {sup 166}Ho dose point-kernel for liver radioembolization treatment optimization and evaluation.
- OSTI ID:
- 22058933
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics, Vol. 83, Issue 3; Other Information: Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0360-3016
- Country of Publication:
- United States
- Language:
- English
Similar Records
Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodology
Development of a SPECT-based 3-D methodology for internal dosimetry of radioimmunotherapy